Metraipolis › archive › dc_68d29c4dbfa1

Comparative analysis of dapagliflozin and linagliptin in managing type 2 diabetes mellitus and heart failure: A retrospective study — Europe PMC PMID:41398811

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41398811
DOI
10.1097/md.0000000000044709
License (as archived)
solo-consultazione
Archived
2026-11-08T03:05:45.473Z
SHA-256 of the archived text
bcb22f44e3a8edbb32e6be5d57b003442dd3d1cafef2a6352055470ed11d9aed
Stable URL of this page
https://metraipolis.com/documento/dc_68d29c4dbfa1

How to cite

Comparative analysis of dapagliflozin and linagliptin in managing type 2 diabetes mellitus and heart failure: A retrospective study — Europe PMC PMID:41398811 — Europe PMC (en), https://europepmc.org/article/MED/41398811 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68d29c4dbfa1 (Metraipolis archive dc_68d29c4dbfa1, sha256 bcb22f44e3a8edbb32e6be5d57b003442dd3d1cafef2a6352055470ed11d9aed)
BibTeX
@misc{dc68d29c4dbfa1,
  title = {Comparative analysis of dapagliflozin and linagliptin in managing type 2 diabetes mellitus and heart failure: A retrospective study — Europe PMC PMID:41398811},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41398811},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68d29c4dbfa1; sha256 bcb22f44e3a8edbb32e6be5d57b003442dd3d1cafef2a6352055470ed11d9aed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41398811. Agents can read the archived copy with the MCP tool read_document.